Edgewise Therapeutics Inc (NASDAQ:EWTX) shares, rose in value on Friday, June 20, with the stock price down by -1.17% to the previous day’s close as strong demand from buyers drove the stock to $14.30.
Actively observing the price movement in the last trading, the stock closed the session at $14.47. Referring to stock’s 52-week performance, its high was $38.12, and the low was $10.60. On the whole, EWTX has fluctuated by -3.83% over the past month.
With the market capitalization of Edgewise Therapeutics Inc currently standing at about $1.50 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-08.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that EWTX’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of EWTX currently trading nearly -2.91% and -1.70% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 41.91, while the 7-day volatility ratio is showing 1.68% which for the 30-day chart, stands at 2.32%. Furthermore, Edgewise Therapeutics Inc (EWTX)’s beta value is 0.29, and its average true range (ATR) is 0.78.
A comparison of Edgewise Therapeutics Inc (EWTX) with its peers suggests the former has fared considerably weaker in the market. EWTX showed an intraday change of -1.17% in last session, and over the past year, it shrunk by -17.67%%.
Data on historical trading for Edgewise Therapeutics Inc (NASDAQ:EWTX) indicates that the trading volumes over the past 3 months, they’ve averaged 1.66 million. According to company’s latest data on outstanding shares, there are 95.21 million shares outstanding.
Nearly 26.71% of Edgewise Therapeutics Inc’s shares belong to company insiders and institutional investors own 74.67% of the company’s shares. The stock has fallen by -46.44% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the EWTX stock heading into the next quarter.
